Adjuvant therapy for residual disease in children with medulloblastoma.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy* / Q000601:surgery; D002528:Cerebellar Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D004735:Energy Transfer; D006801:Humans; D007036:Hypothermia, Induced; D008527:Medulloblastoma / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D010101:Oxygen Consumption; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D011882:Radiotherapy, High-Energy
D000970:Antineoplastic Agents; D011838:Radiation-Sensitizing Agents